Singapore markets close in 7 hours 10 minutes

EyePoint Pharmaceuticals, Inc. (EYPT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.26-0.26 (-3.05%)
At close: 04:00PM EDT
8.65 +0.39 (+4.72%)
After hours: 07:55PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts10101010
Avg. Estimate-0.52-0.58-2.33-3.1
Low estimate-0.66-0.76-2.86-4.55
High estimate-0.34-0.44-1.86-2.32
Year ago EPS-0.61-0.33-1.82-2.33
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts991010
Avg. Estimate9.59M9.26M39.28M13.33M
Low estimateN/AN/AN/AN/A
High estimate14M14M55M23.84M
Year ago sales9.11M15.2M46.02M39.28M
Sales growth (year/est)5.30%-39.10%-14.60%-66.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS0.6-0.51-0.49-0.42
Actual EPS-0.61-0.33-0.33-0.55
Difference-1.210.180.16-0.13
Surprise %-201.70%35.30%32.70%-31.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.52-0.58-2.33-3.1
7 days ago-0.52-0.58-2.33-3.1
30 days ago-0.52-0.58-2.34-3.08
60 days ago-0.45-0.51-1.94-2.53
90 days ago-0.44-0.49-1.89-2.61
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEYPTIndustrySector(s)S&P 500
Current qtr.14.80%N/AN/AN/A
Next qtr.-75.80%N/AN/AN/A
Current year-28.00%N/AN/AN/A
Next year-33.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A